OBJECTIVE: Neonatologists still commonly use creatinine as a proxy for renal clearance, despite issues related to neonatal (patho)physiology and methodology (assay variability). Cystatin C (CysC) has been suggested to be a more reliable biomarker, but assay related differences have also been reported in children and adults. We are unaware of any review on the assay related impact on CysC reference values in newborns. METHODS: A structured literature search was performed on published CysC values in (pre)term neonates. RESULTS: The extensive range (>5-fold) in serum CysC observations in neonates in part relates to the fact that CysC concentrations are higher at birth with subsequent decrease and that CysC concentrations are higher in preterm compared to term neonates. The CysC assay matters while disease characteristics also affect CysC values, but not always in the predicted direction. CONCLUSIONS: Similar to creatinine, the extensive CysC range in neonates is only in part explained by renal (patho)physiology. Its applicability in neonatal medicine can be further improved by use of assay specific reference values, adapted to neonatal renal physiology (e.g. weight, age) and should be compared to a gold standard such as inulin clearance.
OBJECTIVE: Neonatologists still commonly use creatinine as a proxy for renal clearance, despite issues related to neonatal (patho)physiology and methodology (assay variability). Cystatin C (CysC) has been suggested to be a more reliable biomarker, but assay related differences have also been reported in children and adults. We are unaware of any review on the assay related impact on CysC reference values in newborns. METHODS: A structured literature search was performed on published CysC values in (pre)term neonates. RESULTS: The extensive range (>5-fold) in serum CysC observations in neonates in part relates to the fact that CysC concentrations are higher at birth with subsequent decrease and that CysC concentrations are higher in preterm compared to term neonates. The CysC assay matters while disease characteristics also affect CysC values, but not always in the predicted direction. CONCLUSIONS: Similar to creatinine, the extensive CysC range in neonates is only in part explained by renal (patho)physiology. Its applicability in neonatal medicine can be further improved by use of assay specific reference values, adapted to neonatal renal physiology (e.g. weight, age) and should be compared to a gold standard such as inulin clearance.
Authors: Karel Allegaert; Maike Kuppens; Djalila Mekahli; Elena Levtchenko; Florent Vanstapel; Christine Vanhole; John N van den Anker Journal: J Matern Fetal Neonatal Med Date: 2012-02-14
Authors: Sevil Dorum; Ibrahim Silfeler; Bayram Ali Dorum; Dilek B Silfeler; Yekta Canbak; Aysu Say Journal: Indian J Pediatr Date: 2011-12-17 Impact factor: 1.967
Authors: Michael G Shlipak; Kunihiro Matsushita; Johan Ärnlöv; Lesley A Inker; Ronit Katz; Kevan R Polkinghorne; Dietrich Rothenbacher; Mark J Sarnak; Brad C Astor; Josef Coresh; Andrew S Levey; Ron T Gansevoort Journal: N Engl J Med Date: 2013-09-05 Impact factor: 91.245
Authors: Nori J L Smeets; Esther M M Teunissen; Kim van der Velden; Maurice J P van der Burgh; Demi E Linders; Elodie Teesselink; Dirk-Jan A R Moes; Camilla Tøndel; Rob Ter Heine; Arno van Heijst; Michiel F Schreuder; Saskia N de Wildt Journal: Pediatr Nephrol Date: 2022-08-02 Impact factor: 3.651
Authors: Yikun Li; Eric B Dammer; Xiaohui Zhang-Brotzge; Scott Chen; Duc M Duong; Nicholas T Seyfried; Chia-Yi Kuan; Yu-Yo Sun Journal: eNeuro Date: 2017-01-10
Authors: Charlotte I S Barker; Joseph F Standing; Lauren E Kelly; Lauren Hanly Faught; Allison C Needham; Michael J Rieder; Saskia N de Wildt; Martin Offringa Journal: Arch Dis Child Date: 2018-04-19 Impact factor: 3.791
Authors: Joycilene da Silva Barbosa; Geraldo Bezerra da Silva Júnior; Gdayllon Cavalcante Meneses; Alice Maria Costa Martins; Elizabeth De Francesco Daher; Rosângela Pinheiro Gonçalves Machado; Romélia Pinheiro Gonçalves Lemes Journal: J Bras Nefrol Date: 2022 Jan-Mar